AMRI names Joseph D. Sangregorio SVP and chief human resources officer

Tuesday, October 3, 2017

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, announced that Joseph D. Sangregorio has joined the company as senior vice president, chief human resources officer (CHRO), overseeing all HR management and human capital strategies at AMRI.

[Read More]

AMRI acquires Whitehouse Laboratories

Thursday, December 17, 2015

Global CRO Albany Molecular Research Inc. (AMRI) has acquired all the outstanding equity interests of Whitehouse Laboratories, a provider of testing services that includes chemical and material analysis, method development and validation, and quality-control verification services to the pharmaceutical, medical device and personal care industries. Total consideration is $54 million in cash, and an additional $2 million in shares of AMRI common stock contingent upon Whitehouse Labs achieving certain 2015 targets.

[Read More]

AMRI acquires Gadea Pharmaceutical Group

Wednesday, July 22, 2015

Albany Molecular Research (AMRI), a global contract research and manufacturing organization based in Albany, N.Y., has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately held company located in Valladolid, Spain, specializing in technically complex active pharmaceutical ingredients (APIs) and finished drug product. The purchase price was $174 million, including the issuance of 2.2 million shares of common stock to Gadea’s owners, valued at $43.8 million, with the balance paid in cash and through the assumption of existing debt.

[Read More]

AMRI, PerkinElmer collaborate on Buffalo Medical Hub

Friday, June 19, 2015

Global CRO Albany Molecular Research (AMRI) and CRO PerkinElmer are collaborating in connection with the opening of AMRI’s drug discovery center as part of the new Buffalo Medical Innovation and Commercialization Hub (BMIC). Co-located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, the Hub will accelerate drug discovery and innovation, and ultimately support the creation of more than 250 high tech jobs.

[Read More]

CPhI Pharma Awards 2015 open with five new categories

Monday, June 15, 2015

CPhI Worldwide, organized by UBM EMEAhas opened the annual CPhI Pharma Awards for 2015, with five new categories covering the entire pharmaceutical supply chain. Now in their 12th consecutive year, the awards will honor companies and individuals driving the pharma industry forward through innovations, new approaches, technologies and strategies.  

[Read More]

AMRI, HarkerBIO collaborate

Friday, June 5, 2015

Albany Molecular Research (AMRI), a CRO based in Albany, N.Y., has signed a collaborative agreement with Buffalo, N.Y.-based biotechnology company HarkerBIO to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients. AMRI gains access to HarkerBIO’s differentiated high-resolution, structure-determination experience and capabilities. HarkerBIO’s customers will be able to access and benefit from AMRI’s global capabilities, including their integrated drug discovery platforms and solutions.

[Read More]

AMRI to shutter U.K. facility, lay off 62 workers

Monday, April 6, 2015

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has decided to close its Holywell, U.K., facility, which provides chemical development services and small- and large-scale manufacturing services of active pharmaceutical ingredients (API) and intermediates.

[Read More]

AMRI hires VP of International Sales

Thursday, March 5, 2015

Albany Molecular Research (AMRI), a global CRO based in Albany, N.Y., has hired Michael Pettersson to fill the newly created position of vice president of International Sales, effective immediately. He reports to Christopher Conway, senior vice president of Global Sales and Marketing.

[Read More]